Anti-DAB2IP 抗体 (ab87811)
Key features and details
- Rabbit polyclonal to DAB2IP
- Suitable for: WB, IP
- Reacts with: Mouse, Human
- Isotype: IgG
製品の概要
-
製品名
Anti-DAB2IP antibody
DAB2IP 一次抗体 製品一覧 -
製品の詳細
Rabbit polyclonal to DAB2IP -
由来種
Rabbit -
アプリケーション
適用あり: WB, IPmore details -
種交差性
交差種: Mouse, Human
交差が予測される動物種: Rat -
免疫原
Synthetic peptide corresponding to Human DAB2IP aa 850-950.
Database link: Q5VWQ8 -
ポジティブ・コントロール
- WB: human HeLa, mouse TCKMK-1, Renca, 4T1 and CT26.WT cells IP: HeLa cells
-
特記事項
The Life Science industry has been in the grips of a reproducibility crisis for a number of years. Abcam is leading the way in addressing this with our range of recombinant monoclonal antibodies and knockout edited cell lines for gold-standard validation. Please check that this product meets your needs before purchasing.
If you have any questions, special requirements or concerns, please send us an inquiry and/or contact our Support team ahead of purchase. Recommended alternatives for this product can be found below, along with publications, customer reviews and Q&As
製品の特性
-
製品の状態
Liquid -
保存方法
Shipped at 4°C. Upon delivery aliquot and store at -20°C. Avoid freeze / thaw cycles. -
バッファー
pH: 6.8
Preservative: 0.09% Sodium azide
Constituents: 0.1% BSA, Tris buffered saline -
Concentration information loading...
-
精製度
Immunogen affinity purified -
特記事項(精製)
ab87811 was affinity purified using an epitope specific to DAB2IP immobilized on solid support. -
ポリ/モノ
ポリクローナル -
アイソタイプ
IgG -
研究分野
関連製品
-
Compatible Secondaries
-
Isotype control
-
Positive Controls
アプリケーション
The Abpromise guarantee
Abpromise保証は、 次のテスト済みアプリケーションにおけるab87811の使用に適用されます
アプリケーションノートには、推奨の開始希釈率がありますが、適切な希釈率につきましてはご検討ください。
アプリケーション | Abreviews | 特記事項 |
---|---|---|
WB | (2) |
1/2000 - 1/10000. Predicted molecular weight: 132 kDa.
|
IP |
Use at 2-5 µg/mg of lysate.
|
特記事項 |
---|
WB
1/2000 - 1/10000. Predicted molecular weight: 132 kDa. |
IP
Use at 2-5 µg/mg of lysate. |
ターゲット情報
-
関連性
DAB2IP is a Ras GTPase-activating protein (GAP) that acts as a tumor suppressor gene and is inactivated by methylation in prostate and breast cancers. It also interacts with MAP3K5 to disrupt the association of MAP3K5 with the inhibitory 14-3-3 complex. -
細胞内局在
Cytoplasmic -
参照データベース
- Entrez Gene: 153090 Human
- Entrez Gene: 69601 Mouse
- Entrez Gene: 192126 Rat
- Omim: 609205 Human
- SwissProt: Q5VWQ8 Human
- SwissProt: Q3UHC7 Mouse
- SwissProt: Q6P730 Rat
-
別名
- AF9Q34 antibody
- AIP1 antibody
- ASK interacting protein antibody
see all
画像
-
Panel A: Western blot of 0.04µg/ml ab87811 with Lane 1: 50µg, Lane 2: 15g, Lane 3: 5g, HeLa whole cell lysate.
Panel B: HeLa cells with Lane 1: ab87811, Lane2: ab87811 lot: A302-439A, Lane 3: ab87811 lot: A302-440A, Lane 3: Control IgG
-
All lanes : Anti-DAB2IP antibody (ab87811) at 0.1 µg/ml
Lane 1 : TCKMK-1 (mouse kidney epithelial cell line) whole cell lysate
Lane 2 : Renca (murine renal carcinoma cell line) whole cell lysate
Lane 3 : 4T1 (murine mammary carcinoma cell line) whole cell lysate
Lane 4 : CT26.WT (mouse colon carcinoma cell line) whole cell lysate
Predicted band size: 132 kDa
プロトコール
データシートおよび資料
-
SDS download
-
Datasheet download
参考文献 (23)
ab87811 は 23 報の論文で使用されています。
- Huang Q et al. DAB2IP suppresses invadopodia formation through destabilizing ALK by interacting with USP10 in breast cancer. iScience 26:107606 (2023). PubMed: 37664607
- Miller AL et al. DAB2IP Is a Bifunctional Tumor Suppressor That Regulates Wild-Type RAS and Inflammatory Cascades in KRAS Mutant Colon Cancer. Cancer Res 83:1800-1814 (2023). PubMed: 36939385
- Ju L et al. circSLCO1B7 suppresses the malignant progression of hepatocellular carcinoma via the miR-556-3p/DAB2IP axis. Aging (Albany NY) 15:13329-13344 (2023). PubMed: 38015711
- Yun EJ et al. Targeting Wnt/β-catenin-mediated upregulation of oncogenic NLGN3 suppresses cancer stem cells in glioblastoma. Cell Death Dis 14:423 (2023). PubMed: 37443071
- Xiong Z et al. DAB2IP attenuates chemoresistance of triple-negative breast cancer through sequestration of RAC1 to prevent β-catenin nuclear accumulation. Clin Transl Med 12:e1133 (2022). PubMed: 36536485